Dr Jacqui Miot is the Division Director of the Health Economics and Epidemiology Research Office (HE²RO) and holds a joint appointment with the Faculty of Health Sciences, University of Witwatersrand in South Africa. She has successfully led and managed teams in clinical and economic evaluation in the public and private healthcare sector for the past 20 years. Since 2009 she has been conducting health economics and evidence-based driven research to inform policy in the public healthcare setting both in South Africa and sub-Saharan Africa which has included technical advisory work with the National Department of Health. She is currently PI and co-investigator on a number of studies funded by USAID and the Bill and Melinda Gates Foundation. Her research focuses on costing and health economic models in medicine interventions with a particular interest in, HIV and TB, the non-communicable diseases and oncology, working at the intersection of public and private healthcare, identifying opportunities for health systems strengthening. She is a member of the National Essential Medicines List Committee, previously on the Ministerial Advisory Committee for COVID-19 and Vice-chair of the Pricing Committee. She has a B Pharm from Rhodes University, South Africa and obtained her PhD in Neuropharmacology (Faculty of Medicine, London University).